Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aguiar, R. C. T.
Right arrow Articles by Shipp, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aguiar, R. C. T.
Right arrow Articles by Shipp, M. A.
Related Collections
Right arrow Neoplasia
Right arrow Cell Adhesion and Motility
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 15 December 2000, Vol. 96, No. 13, pp. 4328-4334

NEOPLASIA

BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration

Ricardo C. T. Aguiar, Yoshihiro Yakushijin, Samir Kharbanda, Ravi Salgia, Jonathan A. Fletcher, and Margaret A. Shipp

From the Department of Adult Oncology, Dana-Farber Cancer Institute, and the Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Clinical risk factor models such as the International Prognostic Index are used to identify diffuse large B-cell lymphoma (DLB-CL) patients with different risks of death from their diseases. To elucidate the molecular bases for these observed clinical differences in outcome, differential display was used to identify a novel gene, termed BAL (B-aggressive lymphoma), which is expressed at significantly higher levels in fatal high-risk DLB-CLs than in cured low-risk tumors. The major BAL complementary DNA encodes a previously uncharacterized 88-kd nuclear protein with a duplicated N-terminal domain homologous to the nonhistone portion of histone-macroH2A and a C-terminal alpha-helical region with 2 short coiled-coil domains. Of note, the BAL N-terminus and secondary structure resemble those of a recently identified human protein, KIAA1268. In addition, both BAL and KIAA1268 map to chromosome 3q21, further suggesting that these genes belong to a newly identified family. BAL is expressed at increased levels in DLB-CL cell lines with an activated peripheral B cell, rather than a germinal center B cell, phenotype. This observation and the characteristic dissemination of high risk DLB-CLs prompted studies regarding the role of BAL in B-cell migration. In classical transwell assays, stable BAL-overexpressing B-cell lymphoma transfectants had significantly higher rates of migration than vector-only transfectants, indicating that the risk-related BAL gene promotes malignant B-cell migration.

© 2000 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
S. H. Cho, S. Goenka, T. Henttinen, P. Gudapati, A. Reinikainen, C. M. Eischen, R. Lahesmaa, and M. Boothby
PARP-14, a member of the B aggressive lymphoma family, transduces survival signals in primary B cells
Blood, March 12, 2009; 113(11): 2416 - 2425.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Yanagawa, T. Funasaka, S. Tsutsumi, H. Hu, H. Watanabe, and A. Raz
Regulation of Phosphoglucose Isomerase/Autocrine Motility Factor Activities by the Poly(ADP-Ribose) Polymerase Family-14
Cancer Res., September 15, 2007; 67(18): 8682 - 8689.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Goenka, S. H. Cho, and M. Boothby
Collaborator of Stat6 (CoaSt6)-associated Poly(ADP-ribose) Polymerase Activity Modulates Stat6-dependent Gene Transcription
J. Biol. Chem., June 29, 2007; 282(26): 18732 - 18739.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
P. O. Hassa, S. S. Haenni, M. Elser, and M. O. Hottiger
Nuclear ADP-Ribosylation Reactions in Mammalian Cells: Where Are We Today and Where Are We Going?
Microbiol. Mol. Biol. Rev., September 1, 2006; 70(3): 789 - 829.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. Juszczynski, J. L. Kutok, C. Li, J. Mitra, R. C. T. Aguiar, and M. A. Shipp
BAL1 and BBAP Are Regulated by a Gamma Interferon-Responsive Bidirectional Promoter and Are Overexpressed in Diffuse Large B-Cell Lymphomas with a Prominent Inflammatory Infiltrate.
Mol. Cell. Biol., July 1, 2006; 26(14): 5348 - 5359.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-Y. E. Chou, H. T. Chou, and S.-C. Lee
CDK-dependent Activation of Poly(ADP-ribose) Polymerase Member 10 (PARP10)
J. Biol. Chem., June 2, 2006; 281(22): 15201 - 15207.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Goenka and M. Boothby
Selective potentiation of Stat-dependent gene expression by collaborator of Stat6 (CoaSt6), a transcriptional cofactor.
PNAS, March 14, 2006; 103(11): 4210 - 4215.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. C. T. Aguiar, K. Takeyama, C. He, K. Kreinbrink, and M. A. Shipp
B-aggressive Lymphoma Family Proteins Have Unique Domains That Modulate Transcription and Exhibit Poly(ADP-ribose) Polymerase Activity
J. Biol. Chem., October 7, 2005; 280(40): 33756 - 33765.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. G. Smith, F. Wang, K. N. Wilkinson, K. J. Savage, U. Klein, D. S. Neuberg, G. Bollag, M. A. Shipp, and R. C. T. Aguiar
The phosphodiesterase PDE4B limits cAMP-associated PI3K/AKT-dependent apoptosis in diffuse large B-cell lymphoma
Blood, January 1, 2005; 105(1): 308 - 316.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. De, C. Fata-Hartley, S. G. Sawicki, and D. L. Sawicki
Functional Analysis of nsP3 Phosphoprotein Mutants of Sindbis Virus
J. Virol., December 15, 2003; 77(24): 13106 - 13116.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Shi, H.-L. Hsu, A. M. Evens, L. I. Gordon, and R. B. Gartenhaus
Expression of the candidate MCT-1 oncogene in B- and T-cell lymphoid malignancies
Blood, July 1, 2003; 102(1): 297 - 302.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Takeyama, R. C. T. Aguiar, L. Gu, C. He, G. J. Freeman, J. L. Kutok, J. C. Aster, and M. A. Shipp
The BAL-binding Protein BBAP and Related Deltex Family Members Exhibit Ubiquitin-Protein Isopeptide Ligase Activity
J. Biol. Chem., June 6, 2003; 278(24): 21930 - 21937.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. C. T. Aguiar, G. Cox, S. L. Pomeroy, and P. L. M. Dahia
Analysis of the SDHD Gene, the Susceptibility Gene for Familial Paraganglioma Syndrome (PGL1), in Pheochromocytomas
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2890 - 2894.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2000 by American Society of Hematology         Online ISSN: 1528-0020